Alternatively, silencing of KRT19 inhibited hepatocellular cancer (HCC) and cancer stem cell progression by correlating with oncogenic microRNAs, invasive/metastasis markers, and the TGFβ/Smad signaling pathway [17,18,19]. Here, TGFB1 is linked to hepatocellular carcinoma.